Insight journal - Company

Salix Pharmaceuticals: Partnering activity 2009-2014

Posted on 06 October 2014

Tags: , ,

Salix Pharmaceuticals is a leading specialty pharmaceutical company, listed in the top 50 big biotech list by Current Partnering. The company focusses on treating gastroenterology disorders and has numerous products in its pipeline.

Salix Pharmaceuticals announced over 20 partnering / licensing deals since 2009. The company has grown from strength to strength by strategic partnerships and acquisitions.

The number of partnering, collaborative R&D and licensing deals announced varied year on year with a high frequency in 2010. The company is interested in licensing, developing and marketed products in the gastroenterology therapy focus area.

The following figure shows the level of Salix Pharmaceuticals partnering deal announcements since 2009.

Figure 1: Salix Pharmaceuticals partnering deals 2009-2014

Figure 1: Salix Pharmaceuticals partnering deals 2009-2014

Figure 1: Salix Pharmaceuticals partnering deals 2009-2014

Source: Current Agreements, 2014

Analysis of the partnering deals shows a strong emphasis on partnerships in bowel movement and Crohn’s disease. This reflects the focus areas of Salix Pharmaceuticals strongly. The company has partnered with companies such as Lupin Pharmaceuticals, Olon, Redhill Biopharma, Alfa Wassermann for various gastroenterology late stage products

The following table provides an overview of the partnering deals announced by Salix Pharmaceuticals based on specific therapy area disclosed.

Figure 2: Salix Pharmaceuticals partnering deals by therapy area 2009-2014

Figure 2: Salix Pharmaceuticals partnering deals by therapy area 2009-2014

Figure 2: Salix Pharmaceuticals partnering deals by therapy area 2009-2014

Source: Current Agreements, 2014

Further analysis of these deals shows that Salix Pharmaceuticals has a preference for development, licensing and marketed deals.

The following table provides an overview of the partnering deals announced by Salix Pharmaceuticals based on deal type disclosed. 

Figure 3: Salix Pharmaceuticals partnering deals by deal type 2009-2014

Figure 3: Salix Pharmaceuticals partnering deals by deal type 2009-2014

Figure 3: Salix Pharmaceuticals partnering deals by deal type 2009-2014

Source: Current Agreements, 2014

Salix Pharmaceuticals is constantly searching for partners to identify and acquire late stage marketed pharma products and enter into licensing and partnership opportunities.

The following table provides an overview of the partnering deals announced by Salix Pharmaceuticals based on stage of development at signature.

Figure 4: Salix Pharmaceuticals partnering by stage of development 2009-2014

Figure 4: Salix Pharmaceuticals partnering by stage of development 2009-2014

Figure 4: Salix Pharmaceuticals partnering by stage of development 2009-2014

 

Source: Current Agreements, 2014

Salix Pharmaceuticals has entered into high value licensing deals with companies like Progenics and Alfa Wassermann for compounds to treat gastroenterology disorders. The following provides a summary of the top deals by headline value.

Figure 5: Top Salix Pharmaceuticals partnering deals by headline value 2009-2014

Figure 5: Top Salix Pharmaceuticals partnering deals by headline value 2009-2014

Figure 5: Top Salix Pharmaceuticals partnering deals by headline value 2009-2014

 

Source: Current Agreements, 2014

Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Salix Pharmaceuticals 2009-2014

Salix Pharmaceuticals partnering at Current Agreements

View all partnering deals for Salix Pharmaceuticals: 2014 | 2013 | 2012 | 2011 | 2010 | 2009

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Agreements with Salix Pharmaceuticals 2009-2014

More

Summary profile for Salix Pharmaceuticals

Partnering interests for Salix Pharmaceuticals

M&A activity for Salix Pharmaceuticals  

Available reports from Current Partnering

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

Report: Top 50 Big Biotech Partnering and M&A Deals and Alliances

Available resources for deal coverage for Salix Pharmaceuticals

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Salix Pharmaceuticals company profile, recent partnering, M&A and financing news and articles

 

Related

View: CP Insight’s Partnering Scorecard – view top life science partnering deals by value

View:  CP Insight’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

 

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply